💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Exelixis, Inc. (EXEL)
« Back to company indexEXEL Chatter Timeline
Stock Ticker for EXEL
Most Active Tweeters for EXEL
| User | Tweets |
|---|---|
| @PetterTrade | 12 |
| @dailycandlestix | 6 |
| @Tickeron | 4 |
| @newsfilterio | 4 |
| @LeeSinTrade1 | 3 |
Recent Tweets for EXEL
 |
@dailycandlestix $EXEL Major Breakdown Daily appearances since 2010: 93 Close 5 days later ±: Avg: 0.16 SD: 0.99 Worst: -1.82 Best:… https://t.co/0oZQ6f2rEV December 3rd 2021, 9:12pm |
 |
@PetterTrade $EXEL Waiting for Buy signal on EXEL https://t.co/VuJtY83ZSo December 3rd 2021, 8:12pm |
 |
@newsfilterio Study of XL114 in Subjects With Non-Hodgkin's Lymphoma - NCT05144347 $EXEL https://t.co/WQvt5z1MN5 December 3rd 2021, 7:12pm |
 |
@Market_Jungle MJ In Play Alert - Ticker: $EXEL DateTime: 2021-12-03 08:11 Price: 16.79 ATR: 0.59 Daily RVOL 1.35 Beta: 0.81 Short Float: 3.62% December 3rd 2021, 2:12pm |
|
@PetterTrade $EXEL Waiting for Buy signal on EXEL https://t.co/QjlumpBcuw December 2nd 2021, 10:12pm |
 |
@TriathlonTrader @lblegend33 hasnt $exel been a buyout favorite for many years now? December 2nd 2021, 7:12pm |
 |
@MikeBio6 @lblegend33 $exel not happening unless the patent issue has been resolved. That is too much of an overhang. December 2nd 2021, 7:12pm |
 |
@Relly_95 $EXEL $TXNP do me nice please. U guys are here for the long haul December 2nd 2021, 2:12pm |
|
@PetterTrade $EXEL Awaiting Short Signal. Stock Trading Ideas by https://t.co/jZvLPc7Llw https://t.co/5FYeI3S1rG December 2nd 2021, 2:12pm |
 |
@Tickeron $EXEL's price moved below its 50-day Moving Average on November 3, 2021. View odds for this and other indicators:… https://t.co/ArToz9NrhK December 1st 2021, 10:12pm |
|
@dailycandlestix $EXEL Major Breakdown Daily appearances since 2010: 92 Close 5 days later ±: Avg: 0.18 SD: 0.98 Worst: -1.82 Best:… https://t.co/09XreWcsXK December 1st 2021, 9:12pm |
|
@PetterTrade $EXEL Waiting for Short signal on EXEL https://t.co/um6WssJADE December 1st 2021, 8:12pm |
 |
@ShortAlgoTrades $EXEL Awaiting Buy Signal. Stock Trading Ideas by https://t.co/jpmUt7BvVp https://t.co/g8zBY5Zki9 December 1st 2021, 3:12pm |
 |
@ExelixisInc Today, $EXEL fireside chat at Evercore ISI 4th Annual HealthConX Virtual Conference. Details:… https://t.co/PnLmEVRqAq December 1st 2021, 2:12pm |
|
@Market_Jungle MJ In Play Alert - Ticker: $EXEL DateTime: 2021-12-01 07:55 Price: 16.79 ATR: 0.59 Daily RVOL 1.35 Beta: 0.81 Short Float: 3.62% December 1st 2021, 1:12pm |
|
@dailycandlestix $EXEL Major Breakdown Daily appearances since 2010: 92 Close 5 days later ±: Avg: 0.18 SD: 0.98 Worst: -1.82 Best:… https://t.co/FGpMBpU9ld November 30th 2021, 9:11pm |
 |
@guidelines_c $EXEL has an EV of only $4.0B November 30th 2021, 7:11pm |
|
@PetterTrade $EXEL Waiting for buy signal on EXEL https://t.co/wLI5vYrbdP November 30th 2021, 5:11pm |
|
@ShortAlgoTrades $EXEL Awaiting buy Signal. Stock Trading Ideas by https://t.co/jpmUt7BvVp #Investing #trading https://t.co/ayBSFI2VmZ November 30th 2021, 12:11pm |
|
@dailycandlestix $EXEL Major Breakdown Daily appearances since 2010: 91 Close 5 days later ±: Avg: 0.19 SD: 0.99 Worst: -1.82 Best:… https://t.co/xHfC5HstP0 November 29th 2021, 9:11pm |
|
@PetterTrade $EXEL Waiting for buy signal on EXEL https://t.co/MpqYyVzDId November 29th 2021, 4:11pm |
 |
@Stockstowatch3 Check out my latest analysis! $EXEL - Exelixis: Recent Q3 Selloff Offers A Compelling Opportunity https://t.co/wPZMUOas1G November 29th 2021, 2:11pm |
 |
@shortalgotrader $EXEL Awaiting buy signal. Algo Trading Ideas by https://t.co/HF8HfjTBNL https://t.co/0VcORxz0pW November 29th 2021, 11:11am |
 |
@day_trading_de EXEL (EXELIXIS, INC.) ? #Insider #stock alert! ? #Sale on 2021-11-24 - $EXEL ??: Haley Patrick J. (EVP, Commercial)… https://t.co/gbN0x7Ammb November 28th 2021, 11:11pm |
|
@newsfilterio Exelixis: Recent Q3 Selloff Offers A Compelling Opportunity $EXEL https://t.co/2SdQb0Fe1k November 28th 2021, 9:11pm |
 |
@StckPro $EXEL NEW ARTICLE : Exelixis: Recent Q3 Selloff Offers A Compelling Opportunity https://t.co/9Q36sHEnQp Get all the… https://t.co/rSGlYICbaQ November 28th 2021, 9:11pm |
 |
@SeekingAlpha $EXEL - Exelixis: Recent Q3 Selloff Offers A Compelling Opportunity. https://t.co/q05xRpHjad #stockmarket #trading #economy November 28th 2021, 9:11pm |
 |
@ChartMill $EXEL: The EPS has grown by an impressive 22.92% over the past year. https://t.co/pkf6gkb3XR https://t.co/ddE57B1eLB November 28th 2021, 2:11pm |
|
@PetterTrade $EXEL Waiting for Buy signal on EXEL https://t.co/La5j40CgtB November 28th 2021, 1:11am |
 |
@mediasentiment $EXEL new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 208 November 27th 2021, 7:11pm |
|
@ChartMill The industry average Profit Margin is -346.36%. $EXEL outperforms 90% of its industry peers. https://t.co/pkf6gkb3XR https://t.co/UGdgDol0xM November 27th 2021, 7:11pm |
 |
@InsiderForms $EXEL Insider Haley Patrick J. has Sold 17,236 Shares. Title :EVP Commercial Total Cost: $297,321.0 Buy/Sell : Se… https://t.co/qafYtfRMa0 November 27th 2021, 12:11am |
 |
@FlashAlert_me $EXEL [15s. delayed] filed SEC form 4: EVP, Commercial Haley Patrick J.: Disposed 17,236 of Common Stock at price… https://t.co/G6AAaCThz8 November 27th 2021, 12:11am |
|
@newsfilterio $297,321.00 of shares sold by Haley Patrick J. (EVP, Commercial), reported in a new form 4 filed with the SEC $EXEL https://t.co/0Hzt6sAAfT November 27th 2021, 12:11am |
 |
@formwhisperscom #FWSells $EXEL Haley Patrick J., EVP, Commercial of EXELIXIS, INC. sold 17,236 shares on 2021-11-24. https://t.co/awbcNZ6Q6q November 27th 2021, 12:11am |
 |
@fintel_io Insider Haley Patrick J. reports selling 17,236 shares of $EXEL for a total cost of $297,321.00 https://t.co/W5AKBwgMdI #FNTL November 27th 2021, 12:11am |
|
@dailycandlestix $EXEL Major Breakdown Daily appearances since 2010: 91 Close 5 days later ±: Avg: 0.19 SD: 0.99 Worst: -1.82 Best:… https://t.co/scYcMSGpxb November 26th 2021, 9:11pm |
|
@PetterTrade $EXEL Waiting for Buy signal on EXEL https://t.co/lqgvnT8ak6 November 26th 2021, 5:11pm |
 |
@LeeSinTrade1 $EXEL Awaiting buy signal. Stock trading ideas by https://t.co/z9Zossz5Nf https://t.co/NxBcddJhTX November 26th 2021, 2:11pm |
|
@PetterTrade $EXEL Waiting for Buy signal on EXEL https://t.co/IdzyfbcYXP November 26th 2021, 12:11am |
 |
@wallstreetmover H.C. Wainwright Analyst Reiterates Buy Michael King, analyst at H.C. Wainwright, reiterates Buy Rating on $EXEL wi… https://t.co/9sttPCrdXf November 24th 2021, 7:11pm |
|
@Tickeron $EXEL enters a Downtrend as Momentum Indicator dropped below the 0 level on November 3, 2021. View odds for this an… https://t.co/QsVpAwYAzg November 24th 2021, 5:11pm |
|
@PetterTrade $EXEL Waiting for Buy signal on EXEL https://t.co/dvRRaJZloo November 24th 2021, 3:11pm |
 |
@lblegend33 Adding $exel here 17s November 24th 2021, 3:11pm |
|
@Tickeron Good move or bad move? $EXEL RSI Indicator left the oversold zone. #Exelixis #stockmarket #stock… https://t.co/LtXYEerugC November 24th 2021, 3:11pm |
|
@LeeSinTrade1 $EXEL Awaiting buy signal. Trading simplified, free trial at https://t.co/z9Zossz5Nf https://t.co/NfI23Tf09c November 24th 2021, 12:11pm |
|
@newsfilterio $289,800.00 of shares sold by Feldbaum Carl B (Director), reported in a new form 4 filed with the SEC $EXEL https://t.co/Q4IHmlSiuC November 24th 2021, 3:11am |
|
@FlashAlert_me $EXEL [15s. delayed] filed SEC form 4: Director FELDBAUM CARL B: Disposed 20,000 of Common Stock at price $17.62 a… https://t.co/kfb5G53F4S November 24th 2021, 1:11am |
|
@day_trading_de EXEL (EXELIXIS, INC.) ? #Insider #stock alert! ? #Sale on 2021-11-19 - $EXEL ??: FELDBAUM CARL B, total amount $352… https://t.co/iIDQp7f932 November 24th 2021, 1:11am |
|
@fintel_io Insider Carl B Feldbaum reports selling 20,000 shares of $EXEL for a total cost of $352,400.00 https://t.co/qihTNlQosC #FNTL November 24th 2021, 1:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?